-
Pfizer RSV Vaccine That Protects Infants Could Receive FDA Approval This Summer
The single-dose RSV vaccine developed by Pfizer is administered to expectant mothers in the late second-to-third trimester of their pregnancy.
-
Pfizer Says Its Maternal RSV Vaccine Can Protect Newborns From Severe Illness
A new study suggests vaccinating pregnant women protects their newborns from the common but scary respiratory virus called RSV.
-
Pfizer Seeks to Expand Omicron Booster Authorization For Kids 5- to 11-Year-Olds
Pfizer is asking the Food and Drug Administration to expand use of its updated COVID-19 booster shot to children ages 5 to 11.
-
Moderna Sues Pfizer, BioNTech Over Patent Behind COVID-19 Vaccine
The patent infringement lawsuits were filed in the U.S. District Court for the District of Massachusetts and the Regional Court of Düsseldorf in Germany, according to a news release.
-
Moderna Sues Pfizer, BioNTech for Patent Infringement Over mRNA Tech Used to Develop COVID Vaccine
Moderna sued Pfizer and its German partner BioNTech on Friday, alleging that the two companies copied Moderna’s technology in developing their COVID-19 vaccine Comirnaty. Moderna said in a news release that Pfizer and BioNTech infringed on patents filed between 2010 and 2016 covering its mRNA technology, which Moderna used to develop its own COVID-19 vaccine, Spikevax.
-
Pfizer COVID Pill Helped High-Risk Seniors But Showed No Benefit in Younger Adults: Study
The findings reflect the changing nature of the pandemic, in which the vast majority of people already have some protection against the virus due to vaccination or prior infection.
-
Pfizer Asks FDA to Authorize Its Updated COVID Booster Targeting Omicron
Pfizer has asked U.S. regulators to authorize its combination COVID-19 vaccine that adds protection against the newest omicron strains: the BA.4 and BA.5 variants.
-
What the Lyme Disease Vaccine Could Mean for People Living With Long-Term Symptoms
Now entering late-stage clinical trials, the vaccine could be approved as soon as 2025.
-
Pharmacists Can Now Prescribe Drug That Curbs Symptoms Directly to COVID-19 Patients
The Pfizer pill, Paxlovid, is intended for people with COVID-19 who are more likely to become seriously ill. Previously only doctors could prescribe the drug
-
Pfizer Says Tweaked COVID-19 Shots Boost Omicron Protection
Pfizer says tweaking its COVID-19 vaccine to better target the omicron variant is safe and boosts protection.
-
FDA Advisers Endorse Moderna, Pfizer COVID-19 Shots for Kids Under 5
The FDA must still decide whether to take the recommendations and approve the COVID-19 vaccine for kids between six months and 5 years old.
-
FDA Advisers Endorse Moderna, Pfizer COVID-19 Shots for Kids as Young as 6 Months
COVID-19 shots for U.S. infants, toddlers and preschoolers moved a step closer Wednesday.
-
US Making COVID Antiviral Drug More Available at Test Sites
The White House has announced more steps to make the antiviral treatment Paxlovid more accessible across the U.S. as it projects COVID-19 infections will continue to spread over the summer travel season. The nation’s first federally backed test-to-treat site is opening Thursday in Rhode Island. The site will provide patients with immediate access to the drug once they test positive....
-
Pfizer to Offer Low-Cost Medicines, Vaccines to Poor Nations
Pfizer says it will provide nearly two dozen products at not-for-profit prices in some of the world’s poorest countries. That includes its top-selling COVID-19 vaccine and treatment. The pharmaceutical giant said early Wednesday that it is launching a program aimed at improving health equity in 45 lower-income countries. Most of those nations are in Africa. The drugmaker aims to provide...
-
Pfizer Says COVID-19 Vaccine Effective in Children Under 5
Pfizer says it will seek emergency use authorization for a three-dose course of its COVID-19 vaccine in pediatric patients ages 6 months to 5 years old after publishing data from it’s latest study.
-
Pfizer: 3-Dose COVID Vaccine Is Safe, Effective for Kids Under 5
The 18 million kids under 5 are the only group in the U.S. not yet eligible for COVID-19 vaccination.
-
CDC Recommends Pfizer COVID-19 Booster for Children 5 to 11
The center’s director, Dr. Rochelle Walensky, adopted a panel’s recommendation Thursday.
-
Pfizer Hopes to Submit Little-Kid Vaccine Data by Early June
Pfizer now hopes to tell U.S. regulators how well its COVID-19 vaccine works in the littlest kids by late May or early June.
-
Biden Admin to Promote Availability of COVID Antiviral Pill
President Joe Biden and his administration want Americans and their doctors to know that the country has an ample supply of the life-saving COVID-19 antiviral treatment Paxlovid and that it no longer needs to be rationed
-
Pfizer Says COVID-19 Booster Raises Antibodies in Kids 5-11
Pfizer and its partner BioNTech said Thursday new data shows its kid-sized booster shot helps healthy 5- to 11-year-olds rev up virus-fighting antibodies.